The Brenden-Colson Center for Pancreatic Care is a patient-centric research hub for programs that focus on three main areas essential for alleviating suffering from pancreatic diseases: Early Detection, Advanced Therapy, and Quality of Life. The heart of the program is a close collaboration among seven program leaders in a "center-without-walls" that connects clinical activities to laboratory research.

The Center is led by Co-Directors Brett C. Sheppard, M.D., who links his surgical care to the Center's research, and Rosalie C. Sears, Ph.D., who designs and oversees the basic science programs and collaborations. Stellar OHSU researchers Lisa M. Coussens, Ph.D., Emek Demir, Ph.D., Joe W. Gray, Ph.D, and Daniel L. Marks, M.D., Ph.D. along with oncologist Charles Lopez, M.D, Ph.D., lead team projects that advance the search for early detection methods, move promising new stand-alone and combination therapies into the clinical trials pipeline,and search for novel ways to enhance quality of life.

From this foundation, we continue to expand our network of collaborators, partners, and patients to enable us to make the leaps necessary to improve patient care.

Use the navigational bars above to find out more information about the Brenden-Colson Center activities or view a snapshot of the Brenden-Colson Center here.

Referrals

To make a referral to the Pancreatic Cancer High Risk Clinic call (503) 494-4373

National Pancreas Foundation Center Logo

OHSU and the
Brenden-Colson Center have received National Pancreas Foundation Center designation.  Read about the Center's designation.

Donate to the Brenden-Colson Center and help us find cures

Checks made out to the OHSU Foundation may be mailed to BCCPC, or give online:

Brenden-Colson Center Creation

The Brenden-Colson Center was created thanks to a generous donation.  Read about the creation of the Center.

Early Detection Grant

The Brenden-Colson Center has received a competitive $250,000 award from the Pancreatic Cancer Action Network to validate biomarkers able to detect pancreas cancer months or years before patients experience overt symptoms of the disease, using serum samples from patients with newly diagnosed diabetes who later went on to develop cancer.  Find out more about this grant award.